Noah J Nelson on Tuesday, Nov. 26th
Sometimes the high-tech medical news reads straight-up like science fiction.
Northeastern researchers are developing simulation software called Magnasim to more accurately steer simulated drug-filled magnetic nanoparticles to tumor masses where they can safely discharge their contents.
The report at KurweilAI also includes this gem:
“There are only a few groups worldwide that are working on targeted drug delivery using magnetic fields,” (Dinos) Mavroidis explained to KurzweilAI. “We are collaborating with most of them. So far there is no commercial product on the market for targeted drug delivery using magnetic fields or for the simulation software. We expect the Magnasim software to be on the market in 1–2 years.”
This is the kind of medical news everyone should be excited about this week, not that a bunch of Silicon Valley “disruptors” got spanked by the FDA.
Artist impression credit: Northeastern Magnasim team